2-FMA Capsules 50mg research material from Raw Lab Chems
2-FMA Capsules - 50mg Price range: € 12,50 through € 180,00
Back to products
3-FEA Powder research material from Raw Lab Chems
3-FEA Powder Price range: € 29,00 through € 250,00

3-FA Powder

Price range: € 45,90 through € 398,75

3-FA Powder is described as a research material associated with 3-fluoroamphetamine, a meta-fluorinated derivative of amphetamine.

The named compound belongs to the substituted amphetamine and phenethylamine families and contains a fluorine substituent at the 3-position of its aromatic ring.

The supplied source describes the material as a fine crystalline powder intended for controlled analytical and non-clinical laboratory research.

Relevant scientific contexts include chemical identity assessment, chromatographic characterization, structural comparison, and investigation of related substituted amphetamines.

The source reports CAS number 1626-71-7, molecular formula C9H12FN, and molecular weight approximately 153.20 g/mol.

It also refers to third-party analytical verification, Certificate of Analysis documentation, batch tracking, and ISO-compliant manufacturing.

However, no actual batch-specific certificate, independent laboratory report, or manufacturing certification was supplied.

The reported purity of at least 98%, chemical form, stereochemical composition, physical characteristics, and storage stability remain unverified.

The material is not established as a certified reference material or validated quantitative calibration standard.

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

SKU: CERT-P-12766 Category:
Description

3-FA Powder – Fluoroamphetamine Research Material

3-FA Powder – Product Overview

3-FA Powder is the supplied catalog designation for a research material associated with 3-fluoroamphetamine.

The named compound belongs to the substituted amphetamine family and is structurally related to amphetamine and other phenethylamine derivatives.

Its molecular structure contains a fluorine substituent at the meta position of the aromatic ring.

The supplied source presents the product as a fine crystalline powder intended for controlled analytical and non-clinical laboratory research.

The described scientific context includes chemical identification, chromatographic characterization, structural comparison, and investigation of related substituted amphetamines.

These research contexts should be distinguished from verified analytical findings about the actual product batch.

No batch-specific analytical identity certificate, impurity profile, or validated purity result was provided.

The source also refers to independent analytical verification, batch identification, and Certificate of Analysis documentation.

These statements remain unverified without supporting records.

The material is not established as a certified reference material, validated quantitative calibrator, or approved pharmaceutical product.

Chemical Identity & Classification

The supplied source identifies 3-FA as 3-fluoroamphetamine.

It is a meta-fluorinated amphetamine analog belonging to the substituted amphetamine family.

The fluorine substituent distinguishes the named compound from amphetamine and related positional analogs.

The supplied chemical information includes:

  • Common designation: 3-FA
  • Descriptive chemical name: 3-Fluoroamphetamine
  • Systematic chemical name: 1-(3-Fluorophenyl)propan-2-amine
  • Reported CAS Registry Number: 1626-71-7
  • Reported molecular formula: C9H12FN
  • Calculated molecular weight from reported formula: Approximately 153.20 g/mol
  • Chemical classification: Fluorinated substituted amphetamine
  • Reported presentation: Fine crystalline powder
  • Intended designation: Research Use Only

The reported molecular formula and calculated molecular weight are internally consistent for the neutral compound.

However, their assignment to the actual product batch has not been independently verified.

The source does not identify the exact stereochemical composition or establish whether the material is present as a free base or a salt.

These distinctions matter because substituted amphetamines can exhibit stereochemical variation and because a salt form has a different molecular formula and molecular weight from the neutral compound.

The supplied chemical identifiers should be checked against verified structural documentation before publication as definitive specifications.

Researchers may consult PubChem for public chemical-reference information, ensuring that any selected database entry corresponds to the actual molecular structure, stereochemistry, and chemical form being examined.

Chemical & Physical Characteristics

The supplied source describes the product as a fine crystalline powder.

No actual product-specific physical inspection report, image verification, particle-size analysis, or batch appearance record was supplied.

The source does not establish the color, crystal habit, particle-size distribution, bulk density, or moisture content of the actual material.

The named compound contains a meta-fluorinated aromatic group within its substituted amphetamine molecular framework.

This structural feature distinguishes 3-FA from amphetamine and from related positional fluorinated analogs.

The source does not provide experimentally verified solubility measurements or product-specific solvent compatibility records.

It also does not supply a validated stability study, thermal analysis, or measured physical-property dataset.  3-FA Powder

Consequently, the reported powder appearance should be treated as a supplier-provided description rather than an independently confirmed batch characteristic.

The physical properties of a free base may differ from those of a corresponding salt.

Because the source does not establish the actual chemical form, no definitive solubility, melting-point, or storage-performance claim is made.

Purity & Analytical Verification

The supplied source claims ingredient purity of at least 98% and refers to third-party verification.

However, no actual batch-specific Certificate of Analysis or independent laboratory report accompanied that statement.

The reported purity therefore remains a supplier-provided claim rather than an independently verified result.

The source refers to HPLC, GC-MS, NMR spectroscopy, and LC-MS as analytical techniques relevant to chemical characterization.

No chromatogram, mass spectrum, NMR spectrum, impurity profile, or independent laboratory certificate was supplied.

Accordingly, no specific purity result can be confirmed for the actual product batch.

For 3-FA Powder, chemical identity and purity should be established using suitable documented analytical evidence.

The source does not establish whether the claimed purity result refers to a specific batch, chemical form, or analytical method.

It also does not provide information about stereochemical composition, residual solvents, or other potential impurities.

The material is described in reference-oriented research terms.

However, no certified reference-material documentation, assigned measurement value, uncertainty statement, or metrological traceability record was supplied.

The powder should therefore not be represented as a certified quantitative reference standard.

Any definitive analytical claims require actual supporting batch records.

Quality Control & Batch Integrity

The supplied source refers to third-party testing, batch identification, full documentation, and ISO-compliant production conditions.

These statements describe claimed quality-assurance practices.

No actual certificate, independent testing report, manufacturing audit, ISO certificate, or batch-specific quality-control record accompanied the information.

They therefore remain unverified supplier claims.    3-FA Powder

For reproducible analytical documentation, relevant records may include verified chemical identifiers, confirmed stereochemical composition where available, batch number, analytical findings, receipt date, and available storage history.

For 3-FA Powder, chemical identity, ingredient purity, and batch traceability should be distinguished from general supplier descriptions.

The supplied information does not establish independently verified purity, impurity composition, or batch-to-batch consistency.

The source also does not provide evidence of validated analytical performance or certified manufacturing quality.

The Research Use Only designation describes intended positioning but does not independently demonstrate manufacturing quality or analytical traceability.

Claims concerning batch consistency, independent testing, ISO compliance, and validated analytical performance should be supported by actual records.

Safety, Handling & Laboratory Precautions

3-FA is a synthetic substituted amphetamine associated with stimulant-class pharmacological activity and potential toxicological uncertainty.

The supplied source does not provide a complete product-specific toxicological assessment.

Laboratory personnel should consult applicable chemical-safety documentation and institutional procedures before receiving or examining the material.

Relevant precautions include restricted access, appropriate protective equipment, contamination prevention, accidental-exposure procedures, and chemical-waste management.

Powder handling may introduce additional concerns involving airborne particles, surface contamination, and unintended exposure.

The material should remain secured against unauthorized access and separated from food, beverages, and non-research environments.

Because the actual chemical form, purity, impurity profile, and physical characteristics have not been independently confirmed, laboratory documentation should distinguish verified characteristics from supplier-provided statements.

Any accidental exposure or contamination incident should be managed according to institutional emergency procedures.

Packaging, Labeling & Storage

The supplied source describes discreet packaging, batch-aware handling, tracking, and professional shipment arrangements.

No actual packaging specification, container-validation report, or shipment-condition record was provided.

The source recommends storage in a cool, dry environment protected from light.

It also suggests refrigeration at approximately 2–8°C.  3-FA Powder

No validated product-specific stability study was supplied to establish that temperature range as a verified requirement or to support a particular shelf life.

For 3-FA Powder, laboratory inventory records should preserve the product designation, any available batch identifier, receipt details, and relevant storage observations.

Packaging and environmental requirements should be assessed using available safety documentation, relevant stability evidence, and institutional procedures.

No specific shelf life or stability guarantee is asserted.

Intended Research Use & Market Positioning

The supplied scientific context places 3-FA within analytical research involving substituted amphetamine chemical identity, aromatic fluorination, and comparative structural characterization.

The meta-fluoro substituent provides a distinguishing structural feature relevant to chemical analysis.

The source also describes interest in chromatographic profiling, forensic analytical characterization, and investigation of related stimulant-class compounds.

However, no product-specific analytical validation, transporter-binding dataset, or stability study was supplied for the actual powder.

The Raw Lab Chems catalog identifies 3-FA Powder as the product listing discussed here.

For related chemical-family and presentation context, the supplied catalog also includes 3-FA Pellets and 3-FMA Powder.

The first related listing refers to the same named compound in a different finished preparation.

The second refers to a distinct N-methyl-substituted amphetamine analog.

3-FA and 3-FMA should not be treated as chemically identical or analytically interchangeable.

The supplied information does not establish equivalent chemical purity, chemical form, stereochemical composition, or analytical performance across these preparations. 3-FA Powder

These catalog references should not be interpreted as evidence of certified reference-material status or validated quantitative equivalence.

Ordering, Availability & Fulfillment

The supplied source describes professional packaging, international shipping, tracking, and secure handling arrangements.

No current inventory record, confirmed package-size listing, carrier agreement, shipment authorization, or verified delivery information was supplied.

Consequently, no availability, delivery-time, customs-clearance, or transportation-compliance guarantee is asserted.

3-FA may be subject to controlled-substance, analogue, pharmaceutical, or other chemical regulations depending on the jurisdiction.

Institutional acquisition, possession, transportation, importation, and exportation must be assessed under applicable laws.

Research-only labeling does not establish a legal exemption.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

3-FA is a synthetic substituted amphetamine whose possession, acquisition, transfer, transportation, importation, exportation, and laboratory investigation may be restricted or prohibited depending on the jurisdiction.

The supplied information does not establish universal legal status or regulatory authorization.

Institutions remain responsible for determining applicable legal requirements and obtaining any necessary permissions.

No medical approval, consumer-use authorization, or regulatory exemption is implied by this description.

Additional information
Quantity (grams)

2

,

5

,

10

,

25

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “3-FA Powder”
Shipping & Delivery